- Investing Ideas
- /
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
12
0 new
Companies with a Value score of at least 3, ordered by Value score
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | AR$23,100.00 | 1.2% | -23.0% | AR$246.5b | AR$29,166.55 | PE20.5x | E12.0% | 3.3% | ||
GILD | AR$28,100.00 | 1.1% | 16.0% | AR$117.0b | AR$29,678.27 | PE945.5x | E31.1% | 3.2% | ||
BIIB | AR$13,025.00 | -0.6% | -46.1% | AR$21.2b | AR$20,593.91 | PE13x | E10.3% | n/a | ||
BIIBD | US$11.00 | -4.8% | -52.2% | US$21.0b | US$17.39 | PE13x | E10.3% | n/a | ||
MRKD | US$22.00 | 10.3% | -13.9% | US$246.5b | US$27.78 | PE20.5x | E12.0% | 3.3% | ||
NVSD | US$25.30 | 0% | -8.0% | US$184.8b | US$27.67 | PE17.5x | E7.3% | 3.5% | ||
NVS | AR$30,300.00 | 3.1% | -5.3% | AR$186.8b | AR$33,124.15 | PE17.5x | E7.3% | 3.5% | ||
ROSE | AR$110.00 | 1.9% | 1.9% | AR$4.7b | n/a | PE4.7x | n/a | n/a | ||
GILDD | US$24.50 | 0% | 19.8% | US$119.1b | US$25.88 | PE945.5x | E31.1% | 3.2% | ||
BMYD | US$20.20 | 4.7% | n/a | US$119.2b | US$21.03 | PS2.5x | E39.4% | 4.2% | ||
BMY | AR$23,200.00 | 1.9% | 14.2% | AR$119.2b | AR$24,155.46 | PS2.5x | E39.4% | 4.2% | ||
TMOD | US$28.50 | 0% | n/a | US$201.2b | US$35.20 | PE32.8x | E11.5% | 0.3% |
Page 1 of 1